Unichem Laboratories (UNICHEMLAB.NS) Stock Price

Unichem Laboratories Ltd is a prominent pharmaceutical enterprise headquartered in Mumbai, Maharashtra, India, operating within the global health care sector. Listed on the National Stock Exchange of India under the ticker symbol UNICHEMLAB.NS and identified by ISIN INE351A01035, the company has established itself as a significant player in the manufacturing and marketing of pharmaceutical formulations. Since its initial public offering on January 10, 1995, Unichem Laboratories has grown to employ a dedicated workforce of 3,123 full-time professionals who support its extensive operational capabilities. The organization’s core business strategy revolves around the development of complex active pharmaceutical ingredients and various dosage forms, leveraging expertise in process chemistry and product development. This technical proficiency allows the company to produce high-quality medications for a diverse array of therapeutic areas, including gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial treatments, anti-infectives, and pain management solutions. Unichem Laboratories markets its products both as branded generics and as generic alternatives across multiple international markets, ensuring broad accessibility and competitive positioning. In addition to its proprietary product portfolio, the firm engages in contract manufacturing services, catering to specific client needs with immediate-release and extended-release dosage forms, including matrix and pellet technologies. The company also specializes in the production of dry powder injections, syrups, and novel drug delivery systems, while providing comprehensive technology transfer and documentation support. This diversified service offering underscores its commitment to innovation and operational flexibility. The corporate structure includes key subsidiaries that facilitate global reach and market penetration. These include Unichem Pharmaceuticals (USA) Inc, which supports operations in the United States, Unichem Farmaceutica Do Brasil Lta, which manages Brazilian market activities, and Niche Generics Limited UK, which oversees operations in the United Kingdom. Through this international network, Unichem Laboratories continues to expand its footprint in the global pharmaceutical industry. The company’s website, https://www.unichemlabs.com/, serves as a primary resource for stakeholders seeking detailed information about its products, services, and corporate developments. By maintaining a strong focus on quality, innovation, and strategic partnerships, Unichem Laboratories remains a vital contributor to the global health care ecosystem, delivering essential medications to patients worldwide.